Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Ulcerative Colitis: HELP
Christos Polytarchou
Based on 6 articles published since 2009
(Why 6 articles?)
||||
Expertise Level
The expertise of Christos Polytarchou ranks in the
  • Top 1.8%
  • ... of 36,503 published authors worldwide on Ulcerative Colitis
  • ... from 2009 through 2019
  • ... based on contributions to 6 articles on the topic.
Graphical view (beta)
Work Locations
Details
Most likely:    UCLA   Contact    
2016
  • Division of Digestive Diseases, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California; · Center for Systems Biomedicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California; School of Science and Technology, Nottingham Trent University, Nottingham, United Kingdom; · Division of Gastroenterology, Hepatology and Parenteral Nutrition, VA Greater Los Angeles Healthcare System and Department of Medicine David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California; and. · Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California. · Division of Digestive Diseases, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California; Center for Systems Biomedicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California; · Division of Digestive Diseases, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California; · Pubmed 27492330
2015
  • *Center for Systems Biomedicine, Division of Digestive Diseases, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California; †Center for Inflammatory Bowel Diseases, Division of Digestive Diseases, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California; ‡Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts; and §Martinos Center for Biomedical Imaging, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts. · Pubmed 26313695
  • Center for Systems Biomedicine, Division of Digestive Diseases, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California. · Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, The Netherlands; Center for Inflammatory Bowel Diseases, Division of Digestive Diseases, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California. · Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, The Netherlands. · Center for Systems Biomedicine, Division of Digestive Diseases, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California; Center for Inflammatory Bowel Diseases, Division of Digestive Diseases, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California. · Molecular Oncology Research Institute, Tufts Medical Center, Boston, Massachusetts. · Center for Inflammatory Bowel Diseases, Division of Digestive Diseases, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California. · Gail and Gerard Oppenheimer Family Center of Neurobiology of Stress, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California. · Center for HIV Prevention Research, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California. · Center for Systems Biomedicine, Division of Digestive Diseases, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California. Electronic address: · Pubmed 26055138
2014
  • Center for Systems Biomedicine, Division of Digestive Diseases, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California, USA *Christos Polytarchou and Georgios Koukos contributed equally to this work. · Pubmed 24837229
2015
  • *Center for Systems Biomedicine, Division of Digestive Diseases, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California; †Pediatric IBD Center, MassGeneral Hospital for Children, Boston, Massachusetts; ‡Center for Inflammatory Bowel Diseases, Division of Digestive Diseases, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California; and §Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts. · Pubmed 25738378
2013
  • Center for Systems Biomedicine, Division of Digestive Diseases, David Geffen School of Medicine, UCLA, Los Angeles, California; Institute for Molecular Medicine, David Geffen School of Medicine, UCLA, Los Angeles, California; Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Boston, Massachusetts. · Pubmed 23856509
Probable:    Nottingham Trent University      
2016
  • Division of Digestive Diseases, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California; · Center for Systems Biomedicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California; School of Science and Technology, Nottingham Trent University, Nottingham, United Kingdom; · Division of Gastroenterology, Hepatology and Parenteral Nutrition, VA Greater Los Angeles Healthcare System and Department of Medicine David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California; and. · Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California. · Division of Digestive Diseases, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California; Center for Systems Biomedicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California; · Division of Digestive Diseases, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California; · Pubmed 27492330
Probable:    University of Nottingham      
2016
  • Division of Digestive Diseases, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California; · Center for Systems Biomedicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California; School of Science and Technology, Nottingham Trent University, Nottingham, United Kingdom; · Division of Gastroenterology, Hepatology and Parenteral Nutrition, VA Greater Los Angeles Healthcare System and Department of Medicine David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California; and. · Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California. · Division of Digestive Diseases, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California; Center for Systems Biomedicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California; · Division of Digestive Diseases, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California; · Pubmed 27492330
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of all articles written by Christos Polytarchou in 2009-2019 about Ulcerative Colitis:

  • A long noncoding RNA signature for ulcerative colitis identifies IFNG-AS1 as an enhancer of inflammation. 2016
  • Assessment of Circulating MicroRNAs for the Diagnosis and Disease Activity Evaluation in Patients with Ulcerative Colitis by Using the Nanostring Technology. 2015
  • MicroRNA214 Is Associated With Progression of Ulcerative Colitis, and Inhibition Reduces Development of Colitis and Colitis-Associated Cancer in Mice. 2015
  • A microRNA signature in pediatric ulcerative colitis: deregulation of the miR-4284/CXCL5 pathway in the intestinal epithelium. 2015
  • Systems biology in inflammatory bowel diseases: ready for prime time. 2014
  • MicroRNA-124 regulates STAT3 expression and is down-regulated in colon tissues of pediatric patients with ulcerative colitis. 2013
Show List of Full Article Records
Google Searches

Learn more about Christos Polytarchou using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
UCLA
Nottingham Trent University
University of Nottingham
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
UCLA
2016
  • Division of Digestive Diseases, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California; · Center for Systems Biomedicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California; School of Science and Technology, Nottingham Trent University, Nottingham, United Kingdom; · Division of Gastroenterology, Hepatology and Parenteral Nutrition, VA Greater Los Angeles Healthcare System and Department of Medicine David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California; and. · Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California. · Division of Digestive Diseases, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California; Center for Systems Biomedicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California; · Division of Digestive Diseases, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California; · Pubmed 27492330
2015
  • *Center for Systems Biomedicine, Division of Digestive Diseases, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California; †Center for Inflammatory Bowel Diseases, Division of Digestive Diseases, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California; ‡Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts; and §Martinos Center for Biomedical Imaging, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts. · Pubmed 26313695
  • Center for Systems Biomedicine, Division of Digestive Diseases, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California. · Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, The Netherlands; Center for Inflammatory Bowel Diseases, Division of Digestive Diseases, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California. · Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, The Netherlands. · Center for Systems Biomedicine, Division of Digestive Diseases, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California; Center for Inflammatory Bowel Diseases, Division of Digestive Diseases, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California. · Molecular Oncology Research Institute, Tufts Medical Center, Boston, Massachusetts. · Center for Inflammatory Bowel Diseases, Division of Digestive Diseases, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California. · Gail and Gerard Oppenheimer Family Center of Neurobiology of Stress, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California. · Center for HIV Prevention Research, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California. · Center for Systems Biomedicine, Division of Digestive Diseases, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California. Electronic address: · Pubmed 26055138
2014
  • Center for Systems Biomedicine, Division of Digestive Diseases, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California, USA *Christos Polytarchou and Georgios Koukos contributed equally to this work. · Pubmed 24837229
2015
  • *Center for Systems Biomedicine, Division of Digestive Diseases, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California; †Pediatric IBD Center, MassGeneral Hospital for Children, Boston, Massachusetts; ‡Center for Inflammatory Bowel Diseases, Division of Digestive Diseases, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California; and §Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts. · Pubmed 25738378
2013
  • Center for Systems Biomedicine, Division of Digestive Diseases, David Geffen School of Medicine, UCLA, Los Angeles, California; Institute for Molecular Medicine, David Geffen School of Medicine, UCLA, Los Angeles, California; Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Boston, Massachusetts. · Pubmed 23856509
Nottingham Trent University
2016
  • Division of Digestive Diseases, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California; · Center for Systems Biomedicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California; School of Science and Technology, Nottingham Trent University, Nottingham, United Kingdom; · Division of Gastroenterology, Hepatology and Parenteral Nutrition, VA Greater Los Angeles Healthcare System and Department of Medicine David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California; and. · Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California. · Division of Digestive Diseases, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California; Center for Systems Biomedicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California; · Division of Digestive Diseases, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California; · Pubmed 27492330
University of Nottingham
2016
  • Division of Digestive Diseases, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California; · Center for Systems Biomedicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California; School of Science and Technology, Nottingham Trent University, Nottingham, United Kingdom; · Division of Gastroenterology, Hepatology and Parenteral Nutrition, VA Greater Los Angeles Healthcare System and Department of Medicine David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California; and. · Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California. · Division of Digestive Diseases, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California; Center for Systems Biomedicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California; · Division of Digestive Diseases, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California; · Pubmed 27492330
Harvard University Boston
2015
  • *Center for Systems Biomedicine, Division of Digestive Diseases, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California; †Center for Inflammatory Bowel Diseases, Division of Digestive Diseases, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California; ‡Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts; and §Martinos Center for Biomedical Imaging, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts. · Pubmed 26313695
2015
  • *Center for Systems Biomedicine, Division of Digestive Diseases, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California; †Pediatric IBD Center, MassGeneral Hospital for Children, Boston, Massachusetts; ‡Center for Inflammatory Bowel Diseases, Division of Digestive Diseases, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California; and §Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts. · Pubmed 25738378
2013
  • Center for Systems Biomedicine, Division of Digestive Diseases, David Geffen School of Medicine, UCLA, Los Angeles, California; Institute for Molecular Medicine, David Geffen School of Medicine, UCLA, Los Angeles, California; Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Boston, Massachusetts. · Pubmed 23856509
Yearly article counts 00013110000
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.